P642: Anxiety and depression: beyond simple consequences of chronic inflammatory bowel diseases
ECCO '19 Copenhagen
2019
P643: Effectiveness of enhanced recovery after surgery in IBD: a propensity score matched cohort study in a single Italian centre
ECCO '19 Copenhagen
2019
P644: Mindfulness-based stress reduction in adult patients with active Crohn's disease: preliminary findings based on the subjective units of distress scale: an IIRN study
ECCO '19 Copenhagen
2019
P645: Pharmacokinetics and immunogenicity of Infliximab biosimilar in inflammatory bowel disease patients
ECCO '19 Copenhagen
2019
P646: Histological remission in patients with moderate-to-severe ulcerative colitis undergoing biological therapy: a single-centre experience
ECCO '19 Copenhagen
2019
P647: A pilot study: The importance of cognitive flexibility and flexibility in coping with stress for the quality of life in inflammatory bowel disease patients during biological therapy
ECCO '19 Copenhagen
2019
P648: Anti-TNF-α therapy, use of corticosteroids, and colectomy among paediatric and adolescent patients with ulcerative colitis: a nationwide study
ECCO '19 Copenhagen
2019
P649: Anti-TNF agent drug survival in patients with IBD: real-world comparisons of individual anti-TNF agents based on the Swedish National Quality Registry for IBD (SWIBREG)
ECCO '19 Copenhagen
2019
P651: Disease severity and intensity of therapy predicts serious adverse events in paediatric ulcerative colitis: the DEVELOP experience
ECCO '19 Copenhagen
2019
P652: Compare risk factors associated with infectious complication in Crohn’s disease with and without preoperative infliximab
ECCO '19 Copenhagen
2019
P653: Ligation of the intersphincteric fistula tract vs. endorectal advancement flap for high perianal fistulas in Crohn’s disease: a retrospective cohort study
ECCO '19 Copenhagen
2019
P654: Monitoring of drug concentrations to predict remission under ustekinumab induction therapy in Crohn's disease patients
ECCO '19 Copenhagen
2019
P655: Microencapsulated Sodium Butyrate significantly modifies the microbiota in patients with inflammatory bowel disease mimicking prebiotic activity and proving effects on the treatment of the disease
ECCO '19 Copenhagen
2019
P656: Malnutrition rates are highest in pre-surgical Crohn’s disease when compared with active CD, CD in remission and UC in remission
ECCO '19 Copenhagen
2019
P657: Backwash ileitis not influences the risk of the pouchitis, but can increase the risk of the pouch dysplasia
ECCO '19 Copenhagen
2019
P658: Efficacy and safety of thalidomide in adults with refractory Crohn’s disease to maintain clinical remission: a retrospective cohort study
ECCO '19 Copenhagen
2019
P659: Efficacy of switching from infliximab to golimumab in ulcerative colitis patients on deep remission
ECCO '19 Copenhagen
2019
P660: Stability of serum concentrations of infliximab and adalimumab across pregnancy in IBD
ECCO '19 Copenhagen
2019